Press Releases by Category Health & Medicine
Biopreservation Market by type, application and end-user (2016–2021)
According to the report “Global Biopreservation Market" published by Market Data Forecast, the global market is projected to reach USD 4.37 billion by 2021 from USD 2.45 billion in 2016, at a CAGR of 12.3%.Biopreservation refers to extended storage life and enhanced safety of foods using the natural microflora and (or) their antibacterial products. Lactic acid bacteria have a major potential for use in biopreservation because they are safe to…
Asia-Pacific HIV Therapeutics Market worth 2.52 billion USD by 2021
According to the report Asia-Pacific HIV Therapeutics Market, published by Market Data Forecast, the global market is projected to reach USD 2.52 billion by 2021, at a CAGR of 2.1% from 2016 to 2021.
exchange or imparting needles to somebody who is HIV infected. Additionally, HIV can spread from infected mother to child during pregnancy. Here are some of the symptoms of HIV disease are slight fever, weakness, swollen glands, cerebral…
Brain Monitoring Devices Market to Soar at a CAGR of 8.72% to 2021
Brain Monitoring Devices market is Projected to grow at 8.72% CAGR during the period 2017-2021. Network Consulting Industry research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market.
About Brain Monitoring Devices market
Brain monitoring is the process of tracking multiple activities associated with the functioning of the brain. These activities are measured with the help of brain monitoring devices that measure either…
Meat Substitutes Market -2017, Overview and Forecast Report -2022
The Global Meat Substitutes Market Research Report 2017 renders deep perception of the key regional market status of the Meat Substitutes Industry on a Global level that primarily aims the core regions which comprises of continents like Europe, North America, and Asia and the key countries such as United States, Germany, China and Japan.
The report on “Global Meat Substitutes Market” is a professional report which provides thorough knowledge…
ChemoCentryx announces FDA orphan drug designation for Avacopan in the Treatment …
US Food and Drug Administration (FDA) have announced orphan drug designation for chemocentryx’s leading product candidate, avacopan for the treatment of patients suffering with Debilitating Kidney Disease C3 Glomerulopathy (C3G). ChemoCentryx, Inc. is a biopharmaceutical company developing new medications targeted at inflammatory and autoimmune diseases and cancer.
C3G is a severe kidney disease characterized by deposits of proteins from the body’s complement system into and around the kidney’s filtration units, the…
Overactive Bladder Therapeutics Market Showing 1.56% CAGR Growth to 2021: Compan …
The Overactive Bladder Therapeutics Market Research Report is a professional and in-depth study on the current state also focuses on the major drivers and restraints for the key players.
About Overactive Bladder Therapeutics market
Overactive bladder (OAB) is a syndrome that manifests complex symptoms such as urinary urgency with or without urinary incontinence accompanied by increased frequency and nocturia. The disease is more prevalent in women than in men, and the prevalence…
Dynport’s Plague vaccine receives orphan drug status from FDA
DynPort Vaccine Company LLC (DVC), a subsidiary of CSRA, announced that its plague vaccine has received orphan drug designation from US Food and Drug Administration. DVC is developing the recombinant rF1V plague vaccine on behalf of the U.S. Department of Defense (DoD). The vaccine is designed for pre-exposure prophylaxis to fight infection with Yersinia pestis, the causative agent of plague. DVC being a contractor for the Medical Countermeasure Systems Joint…
Boehringer Ingelheim’s investigational anti-CD33 monoclonal antibody BI 836858 r …
US Food and Drug Administration has announced orphan drug designation for Boehringer Ingelheim’s investigational anti-CD33 monoclonal antibody BI 836858 for the treatment of myelodysplastic syndromes (MDS). Boehringer Ingelheim is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, the company operates globally with 145 affiliates and about 50,000 employees, committed to researching, developing, manufacturing and marketing novel treatments for…
Global Healthcare Archiving and eDiscovery Market Outlook, Size, Analysis - Fore …
Market Scenario:
The global Healthcare Archiving and eDiscovery market of is expected to reach US$ 8.4 billion in 2023 from US$ 4.25 billion in 2016 with a CAGR of approximately 9.5% during the forecast period from 2017-2023.
Healthcare is a highly litigious and regulated industry. Many organizations are unprepared with the right systems to cost effectively address these requirements. In the healthcare industry, organizations have to comply with numerous…
EMA grants orphan drug designation to Epidiolex® from GW Pharmaceuticals
GW Pharmaceuticals has announced that European Medicine Agency has granted orphan drug designation to its leading product candidate, Epidiolex® (cannabidiol or CBD) for effective treatment of the treatment of Lennox-Gastaut Syndrome (LGS), treatment-resistant, debilitating childhood-onset epilepsy. Additionally, the investigational drug has received orphan drug status in the treatment of LGS, Dravet syndrome, Tuberous Sclerosis Complex, and Infantile Spasms, each of which are severe infantile-onset, drug-resistant epilepsy syndromes.
The EMA grants an…
CAEL-101 from Fortress Biotech (FBIO) Receives Orphan Drug Designations for Amyl …
U.S. Department of Health & Human Services has confirmed the transfer of two U.S. Food and Drug Administration (FDA) Orphan Drug Designations for CAEL-101 (also known as 11-1F4) from Columbia University (“Columbia”) to Fortress’ subsidiary, Caelum Biosciences, Inc. (“Caelum”). The two Orphan Drug Designations include the use of CAEL-101 as a therapeutic agent for patients with AL amyloidosis, and the use of CAEL-101 as a radio-imaging agent in amyloidosis.
Fortress…
Gamida Cell Announces orphan drug designation for NiCord®
European Medicine Agency (EMA) has announced orphan drug status for NiCord® developed by Gamida cell, a leader in cellular and immune therapies for the treatment of cancer and orphan genetic diseases, to treat haematopoietic stem cell transplantation, also commonly known as bone marrow transplantation (BMT). Presently, the orphan drug is being evaluated internationally as a graft for bone marrow transplantation for patients with blood cancer who do not have a…
Malaria Diagnosis & Treatment Market: Drivers, Challenges & Trends – Market Rese …
Market Highlights
Malaria is a deadly parasitic disease caused by plasmodium species which is transmitted by female anopheles mosquitos. P. falciparum accounts for almost 75% of the occurrence because other types of plasmodium generally cause a milder form of malaria. P. vivax accounts for 20% of the cases with the remaining 5% shared by P. ovale, and P. malariae. According to World Health Organization (WHO), the global incidence of malaria between…
Wound Dressings Global Market Industry Analysis Research Report and Forecast 201 …
Market Research Reports Search Engine (MRRSE) announces the addition of a new report titled “Wound Dressings Market (Traditional Wound Dressings: Wound Closure Products, Basic Wound Care, Anti-infective Dressings; & Advanced Wound Dressings: Films, Foams, Hydrofiber, Hydrocolloids, Hydrogels, Collagen, Alginates) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020”. While traditional wound dressings have been preferred by healthcare practitioners and patients owing to low prices and well-defined reimbursement policies,…
EU Commission grants orphan drug status to ZX008 in Lennox Gastaut Syndrome
Zogenix Inc., a leading biopharmaceutical company dedicated to develop therapies to treat orphan and central nervous system (CNS) disorders, declared that European Commission has announced orphan drug designation for the company’s orphan medicinal product, ZX008 (fenfluramine) for effective treatment of Lennox Gastaut Syndrome (LGS), a refractory, debilitating childhood-onset epilepsy. Presently, the drug is being investigated under Phase 3 clinical trial program in Dravet syndrome, intractable, severe epilepsy that begins…
FDA grants orphan drug designation to EnGeneIC for Targeted EDV™ Nanocells to Tr …
US Food and Drug Administration has announced orphan drug status for EGFR-targeted, doxorubicin-loaded EDV Nano cells for the treatment of glioblastoma multiforme (GBM) the most aggressive form of brain cancer, developed by EnGeneIC Ltd., a clinical stage biopharmaceutical company focused on developing its proprietary EDV™ nanocell platform for targeted cyto-immunotherapy in cancer.
FDA Orphan Drug Designation is granted to investigational therapies that address rare medical diseases or conditions that affect fewer…
FDA announces orphan drug status for aNK Natural Killer Cell Therapy in Merkel C …
NantKwest, Inc. has recently received orphan drug designation from US Food and Drug Administration (FDA) for its leading drug candidate, activated natural killer (aNK) cell therapy for treatment of patients with advanced Merkel cell carcinoma. NantKwest, Inc. is a pioneering, next generation, clinical-stage Immunotherapy Company focused on harnessing the unique power of our immune system using natural killer (NK) cells to treat cancer, infectious diseases and inflammatory diseases.
Presently the drug…
Environmental Health & Safety (EHS)Global Market Industry Analysis Research Repo …
Market Research Reports Search Engine (MRRSE) announces the addition of a new report titled “Environmental Health & Safety (EHS) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024”. Environmental health & safety system is mainly used by the companies to ensure employee safety and well-being at the workplace and to monitor environmental balance.
Request For Sample Report: http://www.mrrse.com/sample/1692
The governing bodies and regional federal agencies are proactively implementing EHS…
Hair Transplant Market expected to reach USD 20428.8 million by the end of 2023
Market Highlights
The global hair transplant market has been evaluated as rapidly growing market and it is expected that the market will continue to grow similarly in the near future. People are getting more conscious about their appearance that is leading the market growth for hair transplant. Increasing awareness, increasing spending, and introduction of new therapies are driving the growth for global hair transplant market.
The market for Hair Transplant…
Global Surgical Lasers Market To Grow At A CAGR Of 9.41% During The Period 2017- …
The study of “Global Surgical Lasers Market 2017-2021” industry is very important to enhance business productivity and for the study of market forecast. This New Report presented by Orbis Reseach contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned: Biolitec, BISON MEDICAL, Boston Scientific, Fotona, and LUMENIS, A.R.C. LASER, Abbott Medical Optics, Alma Lasers, AngioDynamics, Bausch & Lomb , Biolase, Carl…
Urgent Care Centers Global Market Industry Analysis Research Report and Forecast …
Market Research Reports Search Engine (MRRSE) announces the addition of a new report titled “Urgent Care Centers Market (Illness, Injury, Physical, Vaccination, Diagnostic and Screening) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020”. This report on urgent care centers (UCCs) market analyzes the current as well as future prospects of various facets of the urgent care industry by providing an in-depth and comprehensive analysis of the global…
Global Veterinary Drugs Market - Industry Analysis, Size, Share, Growth, Trends, …
The rising number of livestock animals in agriculture and other economic purposes has indeed created the demand for veterinary drugs. This category of medication is the focus of the latest research study added to the huge database of Market Research Reports Search Engine (MRRSE). The report is titled, “Veterinary Drugs Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016-2024”, which analyzes the current and future status of the…
Global Medical Practice Management Software (MPMS) Market Size and Forecast to G …
Latest industry research report on: Global Medical Practice Management Software Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts
Download Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1147802
This industry research report identifies Allscripts, Cerne, CPSI, Epic Systems, General Electric Company, and McKesson as the key vendors in the global medical practice management software (MPMS) market. This industry research report also presents a competitive analysis of the market…
Global Laboratory Information Management System (LIMS) Market: Industry Size, Sh …
Latest industry research report on: Global Laboratory Information Management System Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts
Download Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1068662
This report studies the global Laboratory Information Management System (LIMS) market, analyzes and researches the Laboratory Information Management System (LIMS) development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top…
EMA grants orphan drug designation to aTyr Pharma for the Treatment of Limb Gird …
European Medicine Agency has granted orphan drug designation to aTyr Pharma, Inc. (LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, for company’s novel product, Resolaris™ for the treatment of limb girdle muscular dystrophy (LGMD) patients.
EMA orphan designation is intended to encourage development of medicines for the diagnosis, treatment, or prevention of life-threatening or chronically debilitating conditions that affect no more…
Global Health Care Automation Market: Industry Size, Share, Growth and Forecast …
Latest industry research report on: Global Health Care Automation Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts
Download Sample copy of this Report at :https://www.marketresearchreports.biz/sample/sample/1184738
This report studies the Health Care Automation market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Health Care…
Dermatology Diagnostic Devices and TherapeuticsGlobal Market Industry Analysis R …
Market Research Reports Search Engine (MRRSE) announces the addition of a new report titled “Dermatology Diagnostic Devices and Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024”. This report on the global dermatology diagnostic devices and therapeutics market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and…
Global Clinical Decision Support System Market: Top Manufacturers - Wolters Kluw …
Latest industry research report on: Global Clinical Decision Support System Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts
Download Sample copy of this Report at :https://www.marketresearchreports.biz/sample/sample/1068308
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Clinical Decision Support System in these regions, from 2012 to 2022 (forecast), covering
North America
…
FDA grants orphan drug designation to Miragen Therapeutics
Miragen Therapeutics, a leading biopharmaceutical company has announced that US Food and Drug Administration have granted orphan drug designation to its novel product, MRG-106 for the treatment of mycosis fungoides.
The orphan drug designation is granted to investigational drugs intended to treat rare diseases affecting fewer than 200,000 people nationwide. The status has the potential to provide several benefits to developers, including tax credits for clinical trials costs, exemptions from certain…
Asia-Pacific Infectious Disease Therapeutics Market estimated to grow with a CAG …
The Asia-Pacific ‘Bladder Cancer Therapeutics Market' research report, published by Market Data Forecast estimates that the market itself was worth $14.43 billion in 2016 and expected to grow at a CAGR of 9.27%, to reach $22.48 billion by 2021.
Infectious diseases remain the leading cause of death of children worldwide. New therapeutics are urgently needed, to replace current treatments that are being compromised by resistance phenomena, and to combat emerging threats.
More…
Prometic’s PBI-4050 receives FDA orphan drug status for Alström Syndrome
US Food and Drug Administration has announced orphan drug designation to orally active, anti-fibrotic, lead drug candidate, PBI-4050 Drug, for the treatment of Alstrӧm Syndrome (AS). The disease is chronically debilitating as it can cause permanent blindness, deafness, type 2 diabetes and life-threatening due to progressive organ failure. Presently, there is no satisfactory method to treat patients with AS. The company is investigating drug for its effect on multiple…
European Union grants orphan drug designation to LSK BioPharma’s Apatinib
LSK BioPharma, a leading biopharmaceutical company announced that company’s novel small-molecule angiogenesis inhibitor, Apatinib is awarded with orphan drug designation from European Commission for the effective treatment of gastric cancer.
EMA orphan designation is intended to encourage development of medicines for the diagnosis, treatment, or prevention of life-threatening or chronically debilitating conditions that affect no more than 5 in 10,000 people in the EU. Medicines that receive orphan designation are eligible…
Enterprise Medical Image Viewers Market 2017, Global Overview and Forecast Repor …
The Global Enterprise Medical Image Viewers Market Research Report 2017 renders deep perception of the key regional market status of the Enterprise Medical Image Viewers Industry on a Global level that primarily aims the core regions which comprises of continents like Europe, North America, and Asia and the key countries such as United States, Germany, China and Japan.
The report on “Global Enterprise Medical Image Viewers Market” is a…
FDA grants orphan drug status to Sapience Therapeutics (ST-36)
Sapience Therapeutics, a leading biotechnonology company dedicated to develop therapies for complicated cancer cases, declared that US Food and Drug Administration (FDA) has awarded company’s novel product protein-based therapeutic ST-36, orphan drug designation for the treatment of glioma in patients.
Gliomas are a form of malignant brain cancer that affect approximately 18,000 to 20,000 people annually in the U.S. Nearly 70 percent of gliomas are glioblastoma, the most deadly form of…
Operating Room Integration Systems Market Size-Stryker, Karl Storz, Olympus, Mer …
The Market Research Report, entitled 'Global Operating Room Integration Systems Market Size, Status and Forecast 2022'
provides Market information about Manufacturers, Countries, Type and Application.This Operating Room Integration Systems Industry report also states Company Profile, sales, Operating Room Integration Systems Market revenue and price, market share, market growth and gross margin by regions.The following summary will give an overview of the causes, processes, and possible effects of the market research proposal.
Sample…
Spray Guns Market Size-Terra Universal. Inc, Esco Group, ACMAS Technologies (P) …
The Market Research Report, entitled 'Global Spray Guns Market Size, Status and Forecast 2022'
provides Market information about Manufacturers, Countries, Type and Application.This Spray Guns Industry report also states Company Profile, sales, Spray Guns Market revenue and price, market share, market growth and gross margin by regions.The following summary will give an overview of the causes, processes, and possible effects of the market research proposal.
Sample Copy of Report @ https://goo.gl/o7psKt
Major Manufacturers/Key…
Opko receives orphan drug designation for CUR-1916 in Dravet Syndrome
Opko Health Inc., a leading pharmaceutical company has announced that US Food and Drug Administration has granted orphan drug designation for company’s oligonucleotide-based AntagoNAT (CUR-1916) for the treatment of Dravet Syndrome. Presently, the syndrome does not own any of the approved treatment. Oligonucleotides are synthetic chemical compounds consisting of mixtures of modified DNAs and RNAs.
Orphan drug status is granted to treatments for diseases that affect fewer than 200,000 people in…
Eubiotics Market –2017, Global Industry Analysis and Forecast -2022
The Global Eubiotics Market Research Report 2017 renders deep perception of the key regional market status of the Eubiotics Industry on a Global level that primarily aims the core regions which comprises of continents like Europe, North America, and Asia and the key countries such as United States, Germany, China and Japan.
The report on “Global Eubiotics Market” is a professional report which provides thorough knowledge along with complete…
Clean Room Pass Throughs Market Size-Kimberly-Clark Corporation, Du Pont, Illino …
The Market Research Report, entitled 'Global Clean Room Pass Throughs Market Size, Status and Forecast 2022'
provides Market information about Manufacturers, Countries, Type and Application.This Clean Room Pass Throughs Industry report also states Company Profile, sales, Clean Room Pass Throughs Market revenue and price, market share, market growth and gross margin by regions.The following summary will give an overview of the causes, processes, and possible effects of the market research proposal.
Sample…
FDA orphan drug status given to Exelixis, Inc. (EXEL) for the Treatment of Hepat …
US Food and Drug Administration have granted orphan drug designation to Exelixis’ novel product cabozantinib for the treatment of hepatocellular carcinoma (HCC). A pivotal phase 3 trial (CELESTIAL) of cabozantinib is in process with patients suffering from advanced HCC.
The FDA grants orphan drug designation to drugs and biologics that are intended for the treatment of rare diseases that affect fewer than 200,000 people in the U.S. Orphan drug status is…
Annamycin from Moleculin receives orphan drug status for the Treatment of Acute …
Moleculin Biotech, Inc, a preclinical pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on license agreements with The University of Texas System on behalf of the M.D. Anderson Cancer Center, announced that company’s novel product, Annamycin (also known as “Liposomal Annamycin”), an anthracycline has been designated as orphan drug by the U.S. Food and Drug Administration (FDA) for the treatment of acute myeloid…
Hyperspectral Imaging Systems Market worth 12.71 Billion USD by 2021
According to a new market research report the Hyperspectral Imaging Systems Market is projected to reach USD 12.71 Billion by 2021 from USD 7.41 Billion in 2016 at a CAGR of 11.4% during the forecast period (2016-2021)
Hyperspectral Imaging Systems Market by Component (Hyperspectral Cameras, Accessories), Application (Military Surveillance, Remote Sensing, Machine Vision/Optical Sorting, Life Sciences & Medical Diagnostics) - Global Forecast to 2021
Browse 67 market data Tables and 28 Figures…
Cardiac Catheters and Guidewires Market –2017, Global Industry Analysis and Fore …
The Global Cardiac Catheters and Guidewires Market Research Report 2017 renders deep perception of the key regional market status of the Cardiac Catheters and Guidewires Industry on a Global level that primarily aims the core regions which comprises of continents like Europe, North America, and Asia and the key countries such as United States, Germany, China and Japan.
The report on “Global Cardiac Catheters and Guidewires Market” is a…
FDA grants orphan drug designation to SB-913 Genome Editing Treatment for MPS II
Sangamo Therapeutics, Inc., a leading pharmaceutical company dedicated to develop gene therapies and therapeutic genome editing has recived orphan drug designation from US Food and Drug Administration for company’s genome editing product candidate, SB-913, for the treatment of Mucopolysaccharidosis Type II (MPS II), a rare lysosomal storage disorder. MPS II is caused by mutations in the gene encoding iduronate 2-sulfatase (IDS) enzyme. Using Sangamo’s zinc finger nuclease (ZFN) genome…
Rabies Vaccine Market 2017 - Opportunity Assessment, Analysis, Size, Share and F …
The Global Rabies Vaccine Market Research Report 2017 renders deep perception of the key regional market status of the Rabies Vaccine Industry on a global level that primarily aims the core regions which comprises of continents like Europe, North America, and Asia and the key countries such as United States, Germany, China and Japan.
Request for sample of Rabies Vaccine Market research report @ https://www.qyresearchgroups.com/request-sample/427032
The report on “Global Rabies Vaccine…
DLBCL receives FDA orphan drug designation for eFT508
US Food and Drug Administration has announced orphan drug designation to eFT508, a highly selective inhibitor of MNK1 and MNK2 for the treatment of diffuse large B-cell lymphoma. The drug is developed by eFFECTOR Therapeutics. The company has initiated to evaluate the safety, pharmacokinetics, pharmacodynamics and antitumor activity of the agent in patients with B-cell hematologic malignancies. The company also is conducting a phase 1/phase 2 dose-escalation trial of eFT508…
Global Morphogenetic Protein Sales Market 2017 - Zimmer Biomet, Elizur, Orthofix …
The Global Morphogenetic Protein Sales Industry report gives a comprehensive account of the Global Morphogenetic Protein Sales market. Details such as the size, key players, segmentation, SWOT analysis, most influential trends, and business environment of the market are mentioned in this report. The report features an up-to-date data on key companies product details, revenue figures, and sales. The business model strategies of the key firms in the Morphogenetic Protein Sales…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Global Fermented Drinks Sales Market 2017 - Hain Celestial Group, Kevita Inc., M …
The Global Fermented Drinks Sales Industry report gives a comprehensive account of the Global Fermented Drinks Sales market. Details such as the size, key players, segmentation, SWOT analysis, most influential trends, and business environment of the market are mentioned in this report. The report features an up-to-date data on key companies product details, revenue figures, and sales. The business model strategies of the key firms in the Fermented Drinks Sales…
Global Facial Wipes Sales Market 2017 - Beiersdorf, Johnson & Johnson, SC Johnso …
The Global Facial Wipes Sales Industry report gives a comprehensive account of the Global Facial Wipes Sales market. Details such as the size, key players, segmentation, SWOT analysis, most influential trends, and business environment of the market are mentioned in this report. The report features an up-to-date data on key companies product details, revenue figures, and sales. The business model strategies of the key firms in the Facial Wipes Sales…
Go To Page 1065 1064 1063 1062 1061 1060 1059 1058 1057 1056
